156 related articles for article (PubMed ID: 33902246)
1. [Clinical features and prognosis of patients with leptomeningeal metastases].
Zhang ML; Ma WF; Gao XY; Shi YY; Liu HQ; Jiang YS; Qin LZ; Yuan LP; Li W; Zhang JW
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(16):1154-1159. PubMed ID: 33902246
[No Abstract] [Full Text] [Related]
2. [Analysis of Clinicopathological Feature and Prognosis for
Leptomeningeal Metastasis in Non-small Cell Lung Cancer].
Zhu M; Ren Y; Liu Y; Ban C; Gu H; Wang Z; Zhang Y
Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):533-8. PubMed ID: 27561804
[TBL] [Abstract][Full Text] [Related]
3. The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non-small-cell lung cancer-a retrospective study from one single cancer institute.
Yan W; Jing W; An N; Tian Y; Guo D; Kong L; Zhu H; Yu J
Cancer Med; 2019 Jun; 8(6):2769-2776. PubMed ID: 30993909
[TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal metastasis: Clinical experience of 519 cases.
Hyun JW; Jeong IH; Joung A; Cho HJ; Kim SH; Kim HJ
Eur J Cancer; 2016 Mar; 56():107-114. PubMed ID: 26841095
[TBL] [Abstract][Full Text] [Related]
5. Management of leptomeningeal metastases: Prognostic factors and associated outcomes.
Brower JV; Saha S; Rosenberg SA; Hullett CR; Ian Robins H
J Clin Neurosci; 2016 May; 27():130-7. PubMed ID: 26778048
[TBL] [Abstract][Full Text] [Related]
6. Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis.
Yan W; Liu Y; Li J; Han A; Kong L; Yu J; Zhu H
Radiat Oncol; 2019 Sep; 14(1):168. PubMed ID: 31521171
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors.
Hendriks LEL; Bootsma G; Mourlanette J; Henon C; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Duchemann B; Cousin S; le Pechoux C; Botticella A; De Ruysscher D; Dingemans AC; Besse B
Eur J Cancer; 2019 Jul; 116():182-189. PubMed ID: 31203193
[TBL] [Abstract][Full Text] [Related]
8. A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases.
Yin K; Li YS; Zheng MM; Jiang BY; Li WF; Yang JJ; Tu HY; Zhou Q; Zhong WZ; Yang XN; Chen HJ; Yan HH; Li LL; Wu YL; Zhang XC
Lung Cancer; 2019 May; 131():134-138. PubMed ID: 31027690
[TBL] [Abstract][Full Text] [Related]
9. Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features.
Palma JA; Fernandez-Torron R; Esteve-Belloch P; Fontes-Villalba A; Hernandez A; Fernandez-Hidalgo O; Gallego Perez-Larraya J; Martinez-Vila E
Clin Neurol Neurosurg; 2013 Jan; 115(1):19-25. PubMed ID: 22534095
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal metastasis after effective first-generation EGFR TKI treatment of advanced non-small cell lung cancer.
Wu YL; Zhao Q; Deng L; Zhang Y; Zhou XJ; Li YY; Yu M; Zhou L; Zou BW; Lu Y; Liu YM
Lung Cancer; 2019 Jan; 127():1-5. PubMed ID: 30642536
[TBL] [Abstract][Full Text] [Related]
11. Leptomeningeal Metastases in Patients with NSCLC with EGFR Mutations.
Li YS; Jiang BY; Yang JJ; Tu HY; Zhou Q; Guo WB; Yan HH; Wu YL
J Thorac Oncol; 2016 Nov; 11(11):1962-1969. PubMed ID: 27539328
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of molecular characteristics of cerebrospinal fluid for non-small cell lung cancer patients with leptomeningeal metastasis.
Li N; Liu Y; Duan J; Yang B; Bai H; Sun R; Yu L; Wang J
Thorac Cancer; 2019 Aug; 10(8):1673-1682. PubMed ID: 31368671
[TBL] [Abstract][Full Text] [Related]
13. Prospective study revealed prognostic significance of responses in leptomeningeal metastasis and clinical value of cerebrospinal fluid-based liquid biopsy.
Xu Y; Hu M; Zhang M; Zhong W; Yin X; Sun Y; Chen M; Zhao J; Si X; Wang H; Zhang X; Zhang L; Li J; Guan H; Yang Z; Wang M
Lung Cancer; 2018 Nov; 125():142-149. PubMed ID: 30429013
[TBL] [Abstract][Full Text] [Related]
14. Patient outcomes of whole brain radiotherapy for brain metastases versus leptomeningeal metastases: A retrospective study.
Sakaguchi M; Maebayashi T; Aizawa T; Ishibashi N; Saito T
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e449-e457. PubMed ID: 27620060
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era.
Park JH; Kim YJ; Lee JO; Lee KW; Kim JH; Bang SM; Chung JH; Kim JS; Lee JS
Lung Cancer; 2012 Jun; 76(3):387-92. PubMed ID: 22186628
[TBL] [Abstract][Full Text] [Related]
16. [Epidermal growth factor tyrosine kinase inhibitors used in the treatment of NSCLC patients with leptomeningeal metastasis].
Xu Y; Zhong W; Zhao J; Chen MJ; Zhang L; Li LY; Wang MZ
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):920-924. PubMed ID: 27998469
[No Abstract] [Full Text] [Related]
17. Leptomeningeal metastases in the MRI era.
Clarke JL; Perez HR; Jacks LM; Panageas KS; Deangelis LM
Neurology; 2010 May; 74(18):1449-54. PubMed ID: 20439847
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis.
Oechsle K; Lange-Brock V; Kruell A; Bokemeyer C; de Wit M
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1729-35. PubMed ID: 20204406
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and outcomes in patients with leptomeningeal melanomatosis.
Harstad L; Hess KR; Groves MD
Neuro Oncol; 2008 Dec; 10(6):1010-8. PubMed ID: 18708343
[TBL] [Abstract][Full Text] [Related]
20. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]